Clinical Trials List
2010-09-30 - 2014-08-31
Phase III
Terminated9
ICD-10C61
Malignant neoplasm of prostate
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9185
Malignant neoplasm of prostate
-
Trial Applicant
PPD DEVELOPMENT (HK) LIMITED
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- 熊小澐 Division of Urology
- Chuan-Shu Chen Division of Urology
- Cheng-Kuang Yang Division of Urology
- Shian-Shiang Wang Division of Urology
- Chi-Rei Yang Division of Urology
- Jian-Ri Li Division of Urology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Yeong-Shiau Pu Division of Urology
- Chia-Chi Lin Division of Hematology & Oncology
- - - Division of Urology
- CHUNG-HSIN CHEN Division of Urology
- - - Division of Urology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Chao-Hsiang Chang Division of Urology
- 陳至正 Division of Urology
- Chi-Rei Yang Division of Urology
- Wen-Chi Chen Division of Urology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 朱力行 Division of Nuclear Medicine
- Hsiao-Jen Chung Division of Urology
- Chih-Chieh Lin Division of Urology
- 沈書慧 Division of Radiology
- Tzu-Ping Lin Division of Urology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 林仁泰 Division of Urology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- See-Tong Pang Division of Hematology & Oncology
- 張英勛 Division of Urology
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 康智雄 Division of Urology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 邱斌醫師 Division of Urology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
65 participants
-
Global
1454 participants
